Please use this identifier to cite or link to this item: http://doi.org/10.25358/openscience-8251
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMarengo, Liana-
dc.contributor.authorArmbrust, Fred-
dc.contributor.authorSchoenherr, Caroline-
dc.contributor.authorStorck, Steffen E.-
dc.contributor.authorSchmitt, Ulrich-
dc.contributor.authorZampar, Silvia-
dc.contributor.authorWirths, Oliver-
dc.contributor.authorAltmeppen, Hermann-
dc.contributor.authorGlatzel, Markus-
dc.contributor.authorKaether, Christoph-
dc.contributor.authorWeggen, Sascha-
dc.contributor.authorBecker-Pauly, Christoph-
dc.contributor.authorPietrzik, Claus U.-
dc.date.accessioned2022-12-06T11:29:18Z-
dc.date.available2022-12-06T11:29:18Z-
dc.date.issued2022-
dc.identifier.urihttps://openscience.ub.uni-mainz.de/handle/20.500.12030/8267-
dc.description.abstractβ-Site amyloid precursor protein (APP) cleaving enzyme-1 (BACE1) is the major described β-secretase to generate Aβ peptides in Alzheimer’s disease (AD). However, all therapeutic attempts to block BACE1 activity and to improve AD symptoms have so far failed. A potential candidate for alternative Aβ peptides generation is the metalloproteinase meprin β, which cleaves APP predominantly at alanine in p2 and in this study we can detect an increased meprin β expression in AD brain. Here, we report the generation of the transgenic APP/lon mouse model of AD lacking the functional Mep1b gene (APP/lon × Mep1b−/−). We examined levels of canonical and truncated Aβ species using urea-SDS-PAGE, ELISA and immunohistochemistry in brains of APP/lon mouse × Mep1b−/−. Additionally, we investigated the cognitive abilities of these mice during the Morris water maze task. Aβ1-40 and 1–42 levels are reduced in APP/lon mice when meprin β is absent. Immunohistochemical staining of mouse brain sections revealed that N-terminally truncated Aβ2–x peptide deposition is decreased in APP/lon × Mep1b−/− mice. Importantly, loss of meprin β improved cognitive abilities and rescued learning behavior impairments in APP/lon mice. These observations indicate an important role of meprin β within the amyloidogenic pathway and Aβ production in vivo.en_GB
dc.description.sponsorshipGefördert durch die Deutsche Forschungsgemeinschaft (DFG) - Projektnummer 491381577de
dc.language.isoengde
dc.rightsCC BY*
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/*
dc.subject.ddc610 Medizinde_DE
dc.subject.ddc610 Medical sciencesen_GB
dc.titleMeprin β knockout reduces brain Aβ levels and rescues learning and memory impairments in the APP/lon mouse model for Alzheimer’s diseaseen_GB
dc.typeZeitschriftenaufsatzde
dc.identifier.doihttp://doi.org/10.25358/openscience-8251-
jgu.type.dinitypearticleen_GB
jgu.type.versionPublished versionde
jgu.type.resourceTextde
jgu.organisation.departmentFB 04 Medizinde
jgu.organisation.number2700-
jgu.organisation.nameJohannes Gutenberg-Universität Mainz-
jgu.rights.accessrightsopenAccess-
jgu.journal.titleCellular and molecular life sciencesde
jgu.journal.volume79de
jgu.pages.alternative168de
jgu.publisher.year2022-
jgu.publisher.nameSpringer International Publishing AGde
jgu.publisher.placeCham (ZG)de
jgu.publisher.issn1420-9071de
jgu.organisation.placeMainz-
jgu.subject.ddccode610de
jgu.publisher.doi10.1007/s00018-022-04205-5de
jgu.organisation.rorhttps://ror.org/023b0x485-
jgu.subject.dfgLebenswissenschaftende
Appears in collections:DFG-491381577-H

Files in This Item:
  File Description SizeFormat
Thumbnail
meprin__knockout_reduces_brai-20221110131454718.pdf2.55 MBAdobe PDFView/Open